ESGU vs XBI
iShares MSCI USA ESG Optimized ETF vs SPDR S&P Biotech ETF
- • ESGU has the lower expense ratio at 0.15% vs 0.35% for XBI.
- • ESGU pays a higher dividend yield (0.94%).
Side-by-side metrics
| Metric | ESGU | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.15% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.94% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $17.75B | $10.73B |
YTD return | 10.32% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.03 | 1.10 |
P/E ratio | 27.11 | — |
Last price | $164.99 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
ESGU top holdings
| NVDA | NVIDIA Corp | 7.15% |
| AAPL | Apple Inc | 6.46% |
| MSFT | Microsoft Corp | 4.08% |
| GOOG | Alphabet Inc Class C | 3.54% |
| AMZN | Amazon.com Inc | 3.49% |
| AVGO | Broadcom Inc | 2.64% |
| GOOGL | Alphabet Inc Class A | 2.16% |
| MU | Micron Technology Inc | 1.98% |
| TSLA | Tesla Inc | 1.81% |
| META | Meta Platforms Inc Class A | 1.78% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About ESGU
ESGU (iShares MSCI USA ESG Optimized ETF) is US large/mid-cap stocks with favorable ESG ratings. Managed by iShares, the fund carries $17.7B in assets under management, an expense ratio of 0.15%, a dividend yield of 0.94%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.1% of the portfolio. Real Estate is the fund's largest sector exposure at 2.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.